Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
09/2005
09/06/2005US6939855 Anti-inflammatory compositions and method
09/06/2005US6939854 enzyme inhibitors comprising peptide fragments, conjugated to boronic acids ,forming esters such as 1-amino-3-phenylpropylboronic acid (+)-pinanediol ester, used for prophylaxis of viral diseases
09/06/2005US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia
09/06/2005US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges
09/01/2005WO2005080353A1 Propenoyl hydrazides
09/01/2005WO2005002508B1 Macromolecular platinum chelates
09/01/2005WO2004087742A3 Peptides for reducing symptoms of toxic shock syndrome and septic shck
09/01/2005US20050192269 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005US20050192231 Treating hepatitis with a cytoprotective agents such as benzyloxycarbonyl-valine-aspartic acid(methyl ester)-methyl fluoride or having leucine and isoleucine as replacements for valine; caspase enzyme inhibitors; fas antigen suppressors; neuroprotective agents; antiischemic agents; organ transplants
09/01/2005US20050192230 Process for preparing 1- [N²-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
09/01/2005US20050192212 Viricides; induction immunology response; compounds according to invention specifically inhibit NS3 protease and do not show significant inhibitory activity against other serine proteases such as human leukocyte elastase, porcine pancreatic elastase, bovine pancreatic chymotrypsin, or cysteine proteases
09/01/2005US20050188913 Production of crystalline materials by using high intensity ultrasound
09/01/2005DE102004006893A1 Verfahren zur Herstellung von Process for the preparation of 1[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin
09/01/2005CA2557631A1 Propenoyl hydrazides
08/2005
08/31/2005EP1568707A1 Antihypertensive peptides from casein hydrolysates
08/31/2005EP1567546A2 Aza-peptides
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005CN1662657A Low-cost production of peptides
08/31/2005CN1661034A Method for producing dipeptide
08/31/2005CN1660888A Peptide of decreasing blood pressure of protein of acetes chinensis, preparing method and application
08/30/2005US6936431 Anticancer, antitumor agents; measuring farnesylation of cellular protein
08/25/2005WO2005078116A1 A method of isolating antibacterial peptides and the isolated peptides thereof
08/25/2005WO2005078085A1 Polypeptide having collagen-like structure
08/25/2005WO2005077969A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
08/25/2005WO2005077931A2 Method for the production of 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
08/25/2005WO2005061437A3 Isopeptide gap junction modulators
08/25/2005WO2005021584A3 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
08/25/2005US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
08/25/2005US20050187165 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid
08/25/2005US20050187145 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin
08/25/2005US20050187138 analogs in which one or more amino acids is replaced by a diaza- or triazacyclohexenone, or by an aza-, diaza-, or triazacyclohexenone that is substituted at the alpha -position with a side chain of an amino acid, display an improved ability to assume a beta -strand conformation
08/25/2005US20050186654 Contacting L-alanine methyl ester as carboxy component and L-glutamine as amine component to an enzyme (E. coli JM 109) which catalyzes hydrolysis of amino acid ester to form a dipeptide; enzyme derived from a microorganism belonging to the genus Acetobacter
08/25/2005US20050186651 Incubating the drug candidate in vitro with a human liver microsome incubation mixture in the presence of dansylated glutathione; detecting any drug candidate-dansylated glutathione adducts formed using a fluorescence detector
08/25/2005US20050186634 Peptides for use in culture media
08/25/2005CA2554999A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
08/24/2005EP1565485A1 Perindopril
08/24/2005EP1468003B1 Phosphinic pseudo-peptide derivatives
08/24/2005EP1086122B1 Pyrazinone protease inhibitors
08/24/2005CN1659432A Method for detecting ligands and targets in a mixture
08/24/2005CN1659182A Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
08/24/2005CN1658855A O-substituted hydroxyaryl derivatives
08/24/2005CN1216073C Bioactive peptide of sepuence No.4
08/24/2005CN1216072C Bioactive peptide of sequence No.5
08/24/2005CN1216071C Bioactive peptide of sequcene No.27
08/24/2005CN1216070C Bioactive peptide sequence No.20
08/24/2005CN1216069C Bioctive peptide of sequence No.25
08/24/2005CN1216068C Bioactive peptide of sequence No.14
08/24/2005CN1216067C Bioactive peptide of sequence No.15
08/24/2005CN1216037C Process for preparing 3-hydroxy-3-methyltutyate (HMB) amino acid salt
08/24/2005CN1215774C Albumen oligo peptide and preparing method thereof
08/23/2005US6933352 Amphiphilic compounds having a dendritic branch structure
08/23/2005US6933290 2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives
08/23/2005US6933288 Pyranosyl cytosines: pharmaceutical formulations and methods
08/23/2005US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin
08/23/2005US6933116 Nucleic acid ligand binding site identification
08/23/2005CA2266884C Inhibition of 26s and 20s proteasome by indanones
08/18/2005WO2005075505A1 Peptides that antagonize fpr class receptor mediated signaling
08/18/2005WO2005075502A1 Method of removing transition metals from reaction solutions comprising transition metal byproducts
08/18/2005WO2005054236B1 Substituted quinolines for the treatment of cancer
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005WO2005018549A3 Methods and compositions for tissue repair
08/18/2005WO2005014619A3 Heparin-binding peptides and uses thereof
08/18/2005US20050182138 Dipeptide inhibitors of beta-secretase
08/18/2005US20050181998 Prion inhibiting peptides and derivatives thereof
08/18/2005US20050181989 Selective substrates for matrix metalloproteinases
08/18/2005US20050181454 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization
08/18/2005US20050181447 Opioid metallopeptide compositions and methods
08/18/2005US20050181446 Protein variants having modified immunogenicity
08/17/2005EP1562986A2 Compounds and methods for modulating functions of classical cadherins
08/17/2005EP1562979A2 Tubulysins, method for producing the same and tubulysin preparations
08/17/2005EP1562620A2 Modified cytokines for use in cancer therapy
08/17/2005EP1289951B1 Growth hormone secretagogues
08/17/2005EP1254141B1 Camptothecin -beta-alanine esters with topoisomerase i inibhition
08/17/2005EP1025119B1 Histogranin peptide and their analgesic use
08/17/2005CN1656115A Gamma-secretase inhibitors
08/17/2005CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
08/17/2005CN1656071A New piperidine derivative
08/17/2005CN1655857A Production of crystalline materials by using high intensity ultrasound
08/17/2005CN1215081C Bioactive peptide No.16
08/16/2005US6929796 Methods to treat undesirable immune responses
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005056551A3 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments
08/11/2005WO2005030804A3 A method of modulating cell survival, differentiation and/or synaptic plasticity
08/11/2005WO2004099376A3 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
08/11/2005WO2004056849A3 Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria
08/11/2005US20050176993 Urokinase inhibitors, production and use thereof
08/11/2005US20050176651 Peptide boronic acids useful in making salts thereof
08/11/2005US20050176649 complexing apoptosis protein with a labeled compound to form a complex having the measurable feature; contacting the labeled compound/IAP complex with the test agent; measuring displacement of the complex; drug screening; anticarcinogenic agent
08/11/2005US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases
08/11/2005US20050175755 3-(3-Hydroxy-4-methoxyphenyl)propionaldehyde for use as intermediate in preparation of N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-L- alpha -aspartyl]-L-phenylalanine 1-methyl ester; efficiency
08/11/2005US20050175631 Hiv vaccine and method of use
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561466A2 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
08/10/2005EP1560590A2 Synthetic complementary peptides and ophthalmologic uses thereof
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1042359B1 Kappa receptor opioid peptides
08/10/2005CN1652819A Attenuation of metapneumovirus
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 307